Maternal and fetal outcomes in SCD pregnancies actively managed
. | SS . | SC . |
---|---|---|
Patients | n = 42 | n = 66 |
Spontaneous abortion | 1 | 1 |
Fetal deaths | 9 | 4 |
Maternal deaths | 0 | 2 |
Birth weight, g, mean ± SD (only live birth) | 2500 ± 540 | 2700 ± 430 |
Cesarean section | 18 | 20 |
Patients not transfused during the study period | 19* | 44 |
Patients experiencing SCD-related painful crises | 24 | 35 |
(episodes of crises) | (41) | (46) |
Patients with urinary tract infections | 7 | 17† |
Patients with pulmonary complications | 2 | 0 |
Plasmodium falciparum malaria: | ||
Patients with fever (total episodes) | 10 (14) | 11 (12) |
Patients without fever (total episodes) | 6 (11) | 4 (7) |
Patients with preeclampsia | 0 | 2 |
. | SS . | SC . |
---|---|---|
Patients | n = 42 | n = 66 |
Spontaneous abortion | 1 | 1 |
Fetal deaths | 9 | 4 |
Maternal deaths | 0 | 2 |
Birth weight, g, mean ± SD (only live birth) | 2500 ± 540 | 2700 ± 430 |
Cesarean section | 18 | 20 |
Patients not transfused during the study period | 19* | 44 |
Patients experiencing SCD-related painful crises | 24 | 35 |
(episodes of crises) | (41) | (46) |
Patients with urinary tract infections | 7 | 17† |
Patients with pulmonary complications | 2 | 0 |
Plasmodium falciparum malaria: | ||
Patients with fever (total episodes) | 10 (14) | 11 (12) |
Patients without fever (total episodes) | 6 (11) | 4 (7) |
Patients with preeclampsia | 0 | 2 |